Safety Profile of Using Tocilizumab in the Treatment of Severely Ill Patients with COVID-19
The results of our study suggest a degree of safety in short-term tocilizumab use and suggests that clinicians pay attention to the elevated risk of secondary infection in the patient population treated with tocilizumab and require a ventilator for respiratory support.
Authors
- Nicole Garrett (ORCID: https://orcid.org/0000-0001-6413-0259)
- Elie Gertner (ORCID: https://orcid.org/0000-0003-2285-3146)
- Thomas E. Schmidt
- Michael J Schnaus (ORCID: https://orcid.org/0000-0002-0163-625X)
- Kate Schmiechen
Institutions
- Regions Hospital (US)
- University of Minnesota System (US)
- Park Nicollet Methodist Hospital (US)
Publication Details
- Journal
- Southern Medical Journal
- Published
- 2025-12-01
- DOI
- https://doi.org/10.14423/smj.0000000000001905
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00